Adenylosuccinic acid: an orphan drug with untapped potential
E Rybalka, S Kourakis, CA Bonsett… - Pharmaceuticals, 2023 - mdpi.com
Adenylosuccinic acid (ASA) is an orphan drug that was once investigated for clinical
application in Duchenne muscular dystrophy (DMD). Endogenous ASA participates in …
application in Duchenne muscular dystrophy (DMD). Endogenous ASA participates in …
Impact of exercise training on stress signaling pathway and purine metabolism in healthy and disease models and the influence of ribose supplementation
B Qi - 2023 - vuir.vu.edu.au
Regular exercise improves physical fitness and general health via significant muscle
molecular adaptations. ATP (energy) and its regulation is critical to metabolic homeostasis …
molecular adaptations. ATP (energy) and its regulation is critical to metabolic homeostasis …